332 related articles for article (PubMed ID: 19957161)
21. Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells.
Hadjiyanni I; Siminovitch KA; Danska JS; Drucker DJ
Diabetologia; 2010 Apr; 53(4):730-40. PubMed ID: 20225396
[TBL] [Abstract][Full Text] [Related]
22. Central Nervous System Regulation of Intestinal Lipoprotein Metabolism by Glucagon-Like Peptide-1 via a Brain-Gut Axis.
Farr S; Baker C; Naples M; Taher J; Iqbal J; Hussain M; Adeli K
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1092-100. PubMed ID: 25675997
[TBL] [Abstract][Full Text] [Related]
23. Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways.
Ban K; Noyan-Ashraf MH; Hoefer J; Bolz SS; Drucker DJ; Husain M
Circulation; 2008 May; 117(18):2340-50. PubMed ID: 18427132
[TBL] [Abstract][Full Text] [Related]
24. Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis.
Ali S; Lamont BJ; Charron MJ; Drucker DJ
J Clin Invest; 2011 May; 121(5):1917-29. PubMed ID: 21540554
[TBL] [Abstract][Full Text] [Related]
25. GLP-1 receptor activation inhibits VLDL production and reverses hepatic steatosis by decreasing hepatic lipogenesis in high-fat-fed APOE*3-Leiden mice.
Parlevliet ET; Wang Y; Geerling JJ; Schröder-Van der Elst JP; Picha K; O'Neil K; Stojanovic-Susulic V; Ort T; Havekes LM; Romijn JA; Pijl H; Rensen PC
PLoS One; 2012; 7(11):e49152. PubMed ID: 23133675
[TBL] [Abstract][Full Text] [Related]
26. Cinchonine, a Potential Oral Small-Molecule Glucagon-Like Peptide-1 Receptor Agonist, Lowers Blood Glucose and Ameliorates Non-Alcoholic Steatohepatitis.
Xue H; Xing HJ; Wang B; Fu C; Zhang YS; Qiao X; Guo C; Zhang XL; Hu B; Zhao X; Deng LJ; Zhu XC; Zhang Y; Liu YF
Drug Des Devel Ther; 2023; 17():1417-1432. PubMed ID: 37197367
[TBL] [Abstract][Full Text] [Related]
27. Neprilysin inhibition improves intravenous but not oral glucose-mediated insulin secretion via GLP-1R signaling in mice with
Esser N; Mongovin SM; Parilla J; Barrow BM; Mundinger TO; Fountaine BS; Larmore MJ; Castillo JJ; Akter R; Hull RL; Zraika S
Am J Physiol Endocrinol Metab; 2022 Mar; 322(3):E307-E318. PubMed ID: 35128957
[TBL] [Abstract][Full Text] [Related]
28. Glucagon-like peptide-1 receptor activation modulates pancreatitis-associated gene expression but does not modify the susceptibility to experimental pancreatitis in mice.
Koehler JA; Baggio LL; Lamont BJ; Ali S; Drucker DJ
Diabetes; 2009 Sep; 58(9):2148-61. PubMed ID: 19509017
[TBL] [Abstract][Full Text] [Related]
29. Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors.
Hansotia T; Baggio LL; Delmeire D; Hinke SA; Yamada Y; Tsukiyama K; Seino Y; Holst JJ; Schuit F; Drucker DJ
Diabetes; 2004 May; 53(5):1326-35. PubMed ID: 15111503
[TBL] [Abstract][Full Text] [Related]
30. The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice.
Maida A; Lovshin JA; Baggio LL; Drucker DJ
Endocrinology; 2008 Nov; 149(11):5670-8. PubMed ID: 18669601
[TBL] [Abstract][Full Text] [Related]
31. GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure.
Kim M; Platt MJ; Shibasaki T; Quaggin SE; Backx PH; Seino S; Simpson JA; Drucker DJ
Nat Med; 2013 May; 19(5):567-75. PubMed ID: 23542788
[TBL] [Abstract][Full Text] [Related]
32. Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis.
Li Y; Hansotia T; Yusta B; Ris F; Halban PA; Drucker DJ
J Biol Chem; 2003 Jan; 278(1):471-8. PubMed ID: 12409292
[TBL] [Abstract][Full Text] [Related]
33. Hematopoietic cell- versus enterocyte-derived dipeptidyl peptidase-4 differentially regulates triglyceride excursion in mice.
Varin EM; Hanson AA; Beaudry JL; Nguyen MA; Cao X; Baggio LL; Mulvihill EE; Drucker DJ
JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32663193
[TBL] [Abstract][Full Text] [Related]
34. Intestinal regulation of urinary sodium excretion and the pathophysiology of diabetic kidney disease: a focus on glucagon-like peptide 1 and dipeptidyl peptidase 4.
Vallon V; Docherty NG
Exp Physiol; 2014 Sep; 99(9):1140-5. PubMed ID: 25085841
[TBL] [Abstract][Full Text] [Related]
35. GLP-1 Receptor Blockade Reduces Stimulated Insulin Secretion in Fasted Subjects With Low Circulating GLP-1.
Gray SM; Hoselton AL; Krishna R; Slentz CA; D'Alessio DA
J Clin Endocrinol Metab; 2022 Aug; 107(9):2500-2510. PubMed ID: 35775723
[TBL] [Abstract][Full Text] [Related]
36. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
[TBL] [Abstract][Full Text] [Related]
37. Distinct Neural Sites of GLP-1R Expression Mediate Physiological versus Pharmacological Control of Incretin Action.
Varin EM; Mulvihill EE; Baggio LL; Koehler JA; Cao X; Seeley RJ; Drucker DJ
Cell Rep; 2019 Jun; 27(11):3371-3384.e3. PubMed ID: 31189118
[TBL] [Abstract][Full Text] [Related]
38. New and emerging regulators of intestinal lipoprotein secretion.
Xiao C; Dash S; Morgantini C; Lewis GF
Atherosclerosis; 2014 Apr; 233(2):608-615. PubMed ID: 24534456
[TBL] [Abstract][Full Text] [Related]
39. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
[TBL] [Abstract][Full Text] [Related]
40. GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-/-) mice.
Panjwani N; Mulvihill EE; Longuet C; Yusta B; Campbell JE; Brown TJ; Streutker C; Holland D; Cao X; Baggio LL; Drucker DJ
Endocrinology; 2013 Jan; 154(1):127-39. PubMed ID: 23183176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
